Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AA4500 in Dupuytren's Disease Nodules
NCT02193828Phase 2Completed
- Sponsor
- Endo International plc
- Start
- Jul 2014
- Primary completion
- Dec 2014
- Modality
- Therapeutic Enzymes
- Countries
- 2
01
Overview
A Phase 2 trial of collagenase clostridium histolyticum in Dupuytren's disease, sponsored by Endo International plc. Started Jul 2014; status: completed.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
Dupuytren's disease
Beyond the preview
Go deeper on NCT02193828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02193828.